We have developed new methods for the automated synthesis of MIP nanoparticles compatible with industrial manufacturing processes. The materials are stable to extremes of temperature, pH, pressure and organic solvents and therefore much more robust than their biological counterparts (antibodies, enzymes etc.). MIPs are used in diagnostics (sensors and assays), separations, catalysis and they act as biologically active species. It is our ultimate aim to show that MIPs can form the basis of new classes of therapeutics. Our expertise has been built up over 30 years, and maintained through links with numerous companies from across the globe, engaged in the manufacture of diagnostic devices and polymers. Group has modern state-of-art facilities required for polymer research including computational modules, a range of HPLC, HPLC-MS-MS, NMR, ESR, AFM, and other analytical instruments and sensor platforms such as conductometric, electrochemical, QCM and optical (Biacore 3000).